Sylvain Jereme M
SEC CIK 1681267 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| DXCM | Dexcom | EVP, Chief Financal Off | 146.8K | — | $7.27M | 38 | 2021-09-07 | 2026-09-10 |
Most active insiders at DXCM, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | SAYER KEVIN R | Executive COB, Dir | — | $8.30M |
| 2 | Leach Jacob Steven | Pres, COO | $1.00M | — |
| 3 | Brown Michael Jon | EVP, CLO | — | $873.4K |
| 4 | Coleman Jon | EVP, Chief Commercial Off | — | $722.6K |
| 5 | AUGUSTINOS NICHOLAS | Dir | — | $679.8K |
| 6 | FOLETTA MARK G | Dir | — | $627.2K |
| 7 | Collins Richard Alexander | Dir | — | $389.4K |
| 8 | Sylvain Jereme M | EVP, Chief Financal Off | — | $302.9K |
| 9 | Heller Bridgette P | Dir | — | $277.7K |
| 10 | Stern Sadie | EVP, Chief HR Off | — | $226.7K |
Transactions 38
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-09-14 16:02 | 2026-09-10 | DXCM | Dexcom | Sylvain Jereme M | EVP, Chief Financal Off | S - Sale | $83.27 | -3,638 | 146.8K | -2% | -$302.9K |
| 2026-08-25 16:14 | 2026-08-22 | DXCM | Dexcom | Sylvain Jereme M | EVP, Chief Financal Off | F - Tax | $92.34 | -1,451 | 150.4K | -1.0% | -$134.0K | |
| 2026-05-27 16:39 | 2026-05-22 | DXCM | Dexcom | Sylvain Jereme M | EVP, Chief Financal Off | F - Tax | $71.90 | -1,451 | 151.8K | -0.9% | -$104.3K | |
| 2026-03-10 | 2026-03-08 | DXCM | Dexcom | Sylvain Jereme M | EVP, Chief Financal Off | A - Grant | $0.00 | +48.8K | 172.2K | +40% | $0 | |
| 2026-03-10 | 2026-03-08 | DXCM | Dexcom | Sylvain Jereme M | EVP, Chief Financal Off | F - Tax | $68.10 | -18.9K | 153.3K | -11% | -$1.29M | |
| 2026-02-02 | 2026-01-29 | DXCM | Dexcom | Sylvain Jereme M | EVP, Chief Financal Off | A - Grant | $0.00 | +7,123 | 125.9K | +6% | $0 | |
| 2026-02-02 | 2026-01-29 | DXCM | Dexcom | Sylvain Jereme M | EVP, Chief Financal Off | F - Tax | $73.36 | -2,652 | 123.2K | -2% | -$194.6K | |
| 2025-09-04 | 2025-09-02 | DXCM | Dexcom | Sylvain Jereme M | EVP, Chief Financal Off | S - Sale | $74.17 | -4,824 | 118.7K | -4% | -$357.8K | |
| 2025-03-14 | 2025-03-12 | DXCM | Dexcom | Sylvain Jereme M | EVP, Chief Financal Off | S - Sale | $70.38 | -12.0K | 123.5K | -9% | -$844.6K | |
| M | 2025-03-11 | 2025-03-10 | DXCM | Dexcom | Sylvain Jereme M | EVP, Chief Financal Off | S - Sale | $73.83 | -7,000 | 135.5K | -5% | -$516.8K |
| M | 2025-03-11 | 2025-03-08 | DXCM | Dexcom | Sylvain Jereme M | EVP, Chief Financal Off | A - Grant | $0.00 | +58.7K | 119.7K | +96% | $0 |
| 2025-01-30 | 2025-01-29 | DXCM | Dexcom | Sylvain Jereme M | EVP, Chief Financal Off | S - Sale | $86.91 | -2,090 | 83.5K | -2% | -$181.6K | |
| 2025-01-30 | 2025-01-28 | DXCM | Dexcom | Sylvain Jereme M | EVP, Chief Financal Off | A - Grant | $0.00 | +5,586 | 85.6K | +7% | $0 | |
| 2024-12-17 | 2024-12-16 | DXCM | Dexcom | Sylvain Jereme M | EVP, Chief Financal Off | S - Sale | $76.87 | -744 | 80.0K | -0.9% | -$57.2K | |
| 2024-11-18 | 2024-11-15 | DXCM | Dexcom | Sylvain Jereme M | EVP, Chief Financal Off | S - Sale | $75.51 | -3,500 | 80.8K | -4% | -$264.3K | |
| 2024-09-11 | 2024-09-09 | DXCM | Dexcom | Sylvain Jereme M | EVP, Chief Financal Off | S - Sale | $69.15 | -746 | 84.3K | -0.9% | -$51.6K | |
| 2024-06-11 | 2024-06-10 | DXCM | Dexcom | Sylvain Jereme M | EVP CFO | S - Sale | $115.05 | -745 | 84.9K | -0.9% | -$85.7K | |
| 2024-03-14 | 2024-03-12 | DXCM | Dexcom | Sylvain Jereme M | EVP CFO | S - Sale | $134.41 | -11.7K | 85.5K | -12% | -$1.57M | |
| 2024-03-11 | 2024-03-08 | DXCM | Dexcom | Sylvain Jereme M | EVP CFO | A - Grant | $0.00 | +26.1K | 97.2K | +37% | $0 | |
| 2024-02-21 | 2024-02-20 | DXCM | Dexcom | Sylvain Jereme M | EVP CFO | S - Sale | $116.73 | -3,363 | 71.1K | -5% | -$392.6K | |
| 2024-01-17 | 2024-01-12 | DXCM | Dexcom | Sylvain Jereme M | EVP CFO | A - Grant | $0.00 | +7,171 | 77.2K | +10% | $0 | |
| 2024-01-17 | 2024-01-16 | DXCM | Dexcom | Sylvain Jereme M | EVP CFO | S - Sale | $123.63 | -2,734 | 74.5K | -4% | -$338.0K | |
| 2023-12-19 | 2023-12-18 | DXCM | Dexcom | Sylvain Jereme M | EVP CFO | D - Sale to Iss | $121.85 | -2,932 | 70.1K | -4% | -$357.3K | |
| 2023-08-22 | 2023-08-22 | DXCM | Dexcom | Sylvain Jereme M | EVP CFO | S - Sale | $104.38 | -1,844 | 72.9K | -2% | -$192.5K | |
| 2023-05-23 | 2023-05-22 | DXCM | Dexcom | Sylvain Jereme M | EVP CFO | S - Sale | $117.58 | -2,400 | 74.7K | -3% | -$282.2K | |
| M | 2023-03-14 | 2023-03-10 | DXCM | Dexcom | Sylvain Jereme M | EVP CFO | D - Sale to Iss | $111.40 | -9,618 | 77.1K | -11% | -$1.07M |
| 2023-03-10 | 2023-03-08 | DXCM | Dexcom | Sylvain Jereme M | EVP CFO | A - Grant | $0.00 | +21.8K | 86.7K | +34% | $0 | |
| 2023-02-22 | 2023-02-22 | DXCM | Dexcom | Sylvain Jereme M | EVP CFO | S - Sale | $114.54 | -2,400 | 64.8K | -4% | -$274.9K | |
| 2022-11-22 | 2022-11-21 | DXCM | Dexcom | Sylvain Jereme M | EVP CFO | S - Sale | $112.62 | -2,400 | 67.2K | -3% | -$270.3K | |
| 2022-06-06 | 2022-06-06 | DXCM | Dexcom | Sylvain Jereme M | EVP CFO | S - Sale | $301.57 | -600 | 17.4K | -3% | -$180.9K | |
| M | 2022-03-10 | 2022-03-09 | DXCM | Dexcom | Sylvain Jereme M | EVP, CFO | D - Sale to Iss | $406.06 | -1,951 | 18.0K | -10% | -$792.2K |
| 2022-03-10 | 2022-03-08 | DXCM | Dexcom | Sylvain Jereme M | EVP, CFO | A - Grant | $0.00 | +5,297 | 20.0K | +36% | $0 | |
| 2022-03-04 | 2022-03-04 | DXCM | Dexcom | Sylvain Jereme M | EVP, CFO | S - Sale | $422.94 | -600 | 14.7K | -4% | -$253.8K | |
| 2021-12-17 | 2021-12-15 | DXCM | Dexcom | Sylvain Jereme M | EVP, CFO | A - Grant | $0.00 | +2,925 | 15.2K | +24% | $0 | |
| 2021-12-06 | 2021-12-06 | DXCM | Dexcom | Sylvain Jereme M | EVP, CFO | S - Sale | $517.59 | -600 | 12.3K | -5% | -$310.6K | |
| 2021-11-10 | 2021-11-09 | DXCM | Dexcom | Sylvain Jereme M | EVP, CFO | A - Grant | $634.12 | -634 | 12.9K | -5% | -$402.0K | |
| M | 2021-09-13 | 2021-09-09 | DXCM | Dexcom | Sylvain Jereme M | EVP, CFO | S - Sale | $541.36 | -407 | 13.5K | -3% | -$220.3K |
| 2021-09-08 | 2021-09-07 | DXCM | Dexcom | Sylvain Jereme M | EVP, CFO | S - Sale | $545.41 | -587 | 13.9K | -4% | -$320.2K |
Purchase Sale Sale after option exercise All abbreviations